Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 8802695
Apoptosis signal-regulating kinase 1 inhibitors
granted -
US 8802836
Cloning and recombinant productions of Vespula venom protease and methods of use thereof
granted -
US 8802644
Lipid formulation
granted -
US 8802628
Stable solid formulation of a GC-C receptor agonist polypeptide suitable for oral administration
granted -
US 8802633
Autophagy-inducing peptide analogs
granted -
US 8802656
Purified phospholipid-non-steroidal anti-inflammatory drug associated compositions and methods for preparing and using same
granted -
US 8802107
VEGF antagonist formulations for intravitreal administration
granted -
WO 2014117863
FORMES POLYMORPHES DE SELS D'ADDITION D'ACIDE DE THIOXANTHÈNE-9-YLIDÈNE-1-MÉTHYLPIPÉRIDINES UTILISÉS COMME COMPOSÉS ANTIMIGRAINEUX
granted -
US 8796233
Methods and systems for modulating hormones and related methods, agents and compositions
granted -
US 8796302
Methods related to the treatment of neurodegenerative and inflammatory conditions
granted -
US 8796270
N-[6-(1H-indazol-6-yl)imidazo[1,2-A]pyridin-8-yl]-6-(morpholin-4-yl)pyridazin-3-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor
granted -
US 8796291
A3 adenosine receptor antagonists and partial agonists
granted -
US 8796322
Methods for using 1,2,4-oxadiazole benzoic acid compounds
granted -
US 8796327
Method for inhibiting production of cytokines of T helper cell type II and/or inhibiting production of chemokines using brazilin
granted -
US 8795669
Stabilized formulations containing anti-PCSK9 antibodies
granted -
US 8796320
1,3,4-Oxadiazole-2-carboxamide compound
granted -
US 8796436
Modified iRNA agents
granted -
US 8796444
Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
granted -
US 8796453
Processes and intermediates for producing azaindoles
granted -
US 8796435
Modular functional peptides for the intracellular delivery of nanoparticles
granted -
US 8796254
Methods for using carboxamide, sulfonamide and amine compounds
granted -
US 8795650
Derivation of unlimited quantities of neutrophils or monocyte/dendritic cells
granted -
US 8796022
Generation of functional basal forebrain cholinergic neurons from stem cells
granted -
US 8796008
Influenza A virus vaccines and inhibitors
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.